Brief: ORIC Pharmaceuticals Q2 income from operations USD -24.992 million
10/08/2023 22:33
Aug 10 (Reuters) - ORIC Pharmaceuticals Q2 income from operations USD -24.992 million. * Q2 operating expenses USD 24.992 million * Q2 basic EPS USD -0.5 * Q2 net income USD -22.944 million
Recent news on ORIC Pharmaceuticals
See all newsBrief: Oric® Pharmaceuticals Announces Agreement With Cancer Research UK
ORIC Pharmaceuticals Q1 net loss widens on higher R&D costs
Brief: ORIC Pharmaceuticals Q1 Operating Expenses USD 39.619 Million
Brief: Oric Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ORIC Pharmaceuticals Q4 loss narrows